ADIPOQ and plasma cell myeloma: However, unlike in ST2‐derived BMAds, myeloma cells did not further decrease adiponectin expression in 3T3‐L1 adipocytes, suggesting that the ability of myeloma cells to downregulate adiponectin is specific to BMAds (Supplemental Fig. S4B).